Clinical trial
Effect of Intravenous Nalbuphine Versus Magnesium Sulfate on Emergence Agitation in Pediatric Patients Scheduled for Hypospadias Repair
NCT06306040 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Intravenous Nalbuphine Versus Magnesium Sulfate on Emergence Agitation in Pediatric Patients Scheduled for Hypospadias Repair
- Lead sponsor
- Assiut University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 2, 2024
- Completion date
- January 30, 2025
- Enrollment
- 105 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.